Comments
Loading...

Evolus Analyst Ratings

EOLSNASDAQ
Logo brought to you by Benzinga Data
Q1 2025 Earnings were released on Wed May 7th, after the market close
The most recent conference call was at 16:30 PM, 5 days ago Click to view past webcast
Consensus Rating1
Buy
Highest Price Target1
$27.00
Lowest Price Target1
$18.00
Consensus Price Target1
$22.63

Evolus Analyst Ratings and Price Targets | NASDAQ:EOLS | Benzinga

Evolus Inc has a consensus price target of $22.63 based on the ratings of 9 analysts. The high is $27 issued by HC Wainwright & Co. on April 10, 2025. The low is $18 issued by Truist Securities on May 26, 2023. The 3 most-recent analyst ratings were released by Needham, BTIG, and HC Wainwright & Co. on May 8, 2025, April 17, 2025, and April 10, 2025, respectively. With an average price target of $23.33 between Needham, BTIG, and HC Wainwright & Co., there's an implied 136.17% upside for Evolus Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
3
Jan
1
Feb
3
Mar
3
Apr
1
May
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.2
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Needham
BTIG
HC Wainwright & Co.
Barclays
Stifel

1calculated from analyst ratings

Analyst Ratings for Evolus

Buy NowGet Alert
05/08/2025Buy Now122.67%Needham
Serge Belanger69%
$22 → $22ReiteratesBuy → BuyGet Alert
04/17/2025Buy Now112.55%BTIG
Sam Eiber34%
→ $21Initiates → BuyGet Alert
04/10/2025Buy Now173.28%HC Wainwright & Co.
Douglas Tsao49%
$27 → $27ReiteratesBuy → BuyGet Alert
04/09/2025Buy Now122.67%Needham
Serge Belanger69%
$22 → $22ReiteratesBuy → BuyGet Alert
03/05/2025Buy Now153.04%Barclays
Balaji Prasad64%
$22 → $25MaintainsOverweightGet Alert
03/05/2025Buy Now173.28%HC Wainwright & Co.
Douglas Tsao49%
$27 → $27ReiteratesBuy → BuyGet Alert
03/05/2025Buy Now122.67%Needham
Serge Belanger69%
$22 → $22ReiteratesBuy → BuyGet Alert
02/14/2025Buy Now173.28%HC Wainwright & Co.
Douglas Tsao49%
$27 → $27ReiteratesBuy → BuyGet Alert
01/27/2025Buy Now122.67%Barclays
Balaji Prasad64%
$20 → $22MaintainsOverweightGet Alert
01/22/2025Buy Now173.28%HC Wainwright & Co.
Douglas Tsao49%
$27 → $27ReiteratesBuy → BuyGet Alert
01/21/2025Buy Now122.67%Needham
Serge Belanger69%
$22 → $22ReiteratesBuy → BuyGet Alert
11/07/2024Buy Now173.28%HC Wainwright & Co.
Douglas Tsao49%
$27 → $27ReiteratesBuy → BuyGet Alert
11/01/2024Buy Now173.28%HC Wainwright & Co.
Douglas Tsao49%
$27 → $27ReiteratesBuy → BuyGet Alert
10/03/2024Buy Now173.28%HC Wainwright & Co.
Douglas Tsao49%
$27 → $27ReiteratesBuy → BuyGet Alert
09/16/2024Buy NowCantor Fitzgerald
Louise Chen59%
Reiterates → OverweightGet Alert
09/13/2024Buy Now102.43%Barclays
Balaji Prasad64%
$16 → $20MaintainsOverweightGet Alert
09/13/2024Buy Now122.67%Needham
Serge Belanger69%
$22 → $22ReiteratesBuy → BuyGet Alert
09/09/2024Buy NowCantor Fitzgerald
Louise Chen59%
Reiterates → OverweightGet Alert
08/01/2024Buy Now173.28%HC Wainwright & Co.
Douglas Tsao49%
$27 → $27ReiteratesBuy → BuyGet Alert
08/01/2024Buy Now122.67%Needham
Serge Belanger69%
$22 → $22ReiteratesBuy → BuyGet Alert
06/20/2024Buy NowCantor Fitzgerald
Louise Chen59%
Reiterates → OverweightGet Alert
05/21/2024Buy Now173.28%HC Wainwright & Co.
Douglas Tsao49%
$27 → $27ReiteratesBuy → BuyGet Alert
05/08/2024Buy Now122.67%Needham
Serge Belanger69%
$22 → $22ReiteratesBuy → BuyGet Alert
05/08/2024Buy Now173.28%HC Wainwright & Co.
Douglas Tsao49%
$27 → $27ReiteratesBuy → BuyGet Alert
04/10/2024Buy Now122.67%Needham
Serge Belanger69%
$22 → $22ReiteratesBuy → BuyGet Alert
03/08/2024Buy Now122.67%Needham
Serge Belanger69%
$22 → $22ReiteratesBuy → BuyGet Alert
03/08/2024Buy Now173.28%HC Wainwright & Co.
Douglas Tsao49%
$27 → $27ReiteratesBuy → BuyGet Alert
03/08/2024Buy Now153.04%Stifel
Annabel Samimy66%
$23 → $25ReiteratesBuy → BuyGet Alert
03/08/2024Buy Now132.79%Mizuho
Uy Ear60%
$20 → $23MaintainsBuyGet Alert
03/01/2024Buy Now173.28%HC Wainwright & Co.
Douglas Tsao49%
$27 → $27ReiteratesBuy → BuyGet Alert
01/29/2024Buy Now61.94%Barclays
Balaji Prasad64%
$10 → $16UpgradeEqual-Weight → OverweightGet Alert
01/17/2024Buy Now173.28%HC Wainwright & Co.
Douglas Tsao49%
$27 → $27ReiteratesBuy → BuyGet Alert
12/20/2023Buy Now122.67%Needham
Serge Belanger69%
$22 → $22ReiteratesBuy → BuyGet Alert
08/03/2023Buy Now173.28%HC Wainwright & Co.
Douglas Tsao49%
$16 → $27MaintainsBuyGet Alert
08/03/2023Buy Now122.67%Needham
Serge Belanger69%
→ $22ReiteratesBuy → BuyGet Alert
07/28/2023Buy Now61.94%HC Wainwright & Co.
Douglas Tsao49%
→ $16ReiteratesBuy → BuyGet Alert
06/07/2023Buy Now102.43%Mizuho
Uy Ear60%
$17 → $20MaintainsBuyGet Alert
05/26/2023Buy Now82.19%Truist Securities
Gregory Fraser29%
$14 → $18MaintainsBuyGet Alert
05/10/2023Buy Now122.67%Needham
Serge Belanger69%
$18 → $22MaintainsBuyGet Alert
05/10/2023Buy Now61.94%HC Wainwright & Co.
Douglas Tsao49%
$15 → $16MaintainsBuyGet Alert
03/09/2023Buy Now82.19%Needham
Serge Belanger69%
→ $18Reiterates → BuyGet Alert
03/09/2023Buy Now51.82%HC Wainwright & Co.
Douglas Tsao49%
→ $15Reiterates → BuyGet Alert
02/13/2023Buy Now82.19%Needham
Serge Belanger69%
→ $18Reiterates → BuyGet Alert
01/19/2023Buy Now72.06%Mizuho
Uy Ear60%
$15 → $17MaintainsBuyGet Alert
01/19/2023Buy Now102.43%SVB Leerink
Marc Goodman75%
$18 → $20MaintainsOutperformGet Alert
06/23/2022Buy Now82.19%Needham
Serge Belanger69%
→ $18Initiates → BuyGet Alert
05/13/2022Buy Now1.21%Barclays
Balaji Prasad64%
$8 → $10UpgradeUnderweight → Equal-WeightGet Alert
05/12/2022Buy Now1.21%Barclays
Balaji Prasad64%
$8 → $10UpgradeUnderweight → Equal-WeightGet Alert

FAQ

Q

What is the target price for Evolus (EOLS) stock?

A

The latest price target for Evolus (NASDAQ:EOLS) was reported by Needham on May 8, 2025. The analyst firm set a price target for $22.00 expecting EOLS to rise to within 12 months (a possible 122.67% upside). 22 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Evolus (EOLS)?

A

The latest analyst rating for Evolus (NASDAQ:EOLS) was provided by Needham, and Evolus reiterated their buy rating.

Q

When was the last upgrade for Evolus (EOLS)?

A

The last upgrade for Evolus Inc happened on January 29, 2024 when Barclays raised their price target to $16. Barclays previously had an equal-weight for Evolus Inc.

Q

When was the last downgrade for Evolus (EOLS)?

A

There is no last downgrade for Evolus.

Q

When is the next analyst rating going to be posted or updated for Evolus (EOLS)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Evolus, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Evolus was filed on May 8, 2025 so you should expect the next rating to be made available sometime around May 8, 2026.

Q

Is the Analyst Rating Evolus (EOLS) correct?

A

While ratings are subjective and will change, the latest Evolus (EOLS) rating was a reiterated with a price target of $22.00 to $22.00. The current price Evolus (EOLS) is trading at is $9.88, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch